Testosterone and type 2 diabetes in men

References

• Grossman M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrin Metab 2011;96:2341–58
   PubMedGoogle Scholar
• Jones D. Effects of testosterone on type 2 diabetes and components of metabolic syndrome. J Diabetes 2010;2:146–56
   PubMed Web of Science ®Google Scholar
• Ding E, Song Y, Malik V, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes. JAMA 2006;295:1288–99
   PubMed Web of Science ®Google Scholar
• Kelly D, Jones T. Testosterone: a metabolic hormone in health and disease. J Endocrinol 2013;217:R25–45
   PubMed Web of Science ®Google Scholar
• Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996;45:1605–9
   PubMed Web of Science ®Google Scholar
• Laaksonen, D, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036–41
   PubMed Web of Science ®Google Scholar
• Tahara N, Imaizumi T, Takeuchi M, Yamagishi S. Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men. Oxid Med Cell Longev 2010;3:262–5
   PubMedGoogle Scholar
• Schipf S, Haring R, Friedrich N, et al. Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP). Aging Male 2011;14:168–75
   PubMed Web of Science ®Google Scholar
• Goto A, Morita A, Goto M, et al. Associations of sex hormone-binding globulin and testosterone with diabetes among men and women (the Saku Diabetes study): a case control study. Cardiovasc Diabetol 2012;11:130–7
   PubMed Web of Science ®Google Scholar
• Shin J, Park E, Park B, et al. High-normal glucose levels in non-diabetic and pre-diabetic men are associated with decreased testosterone levels. Korean J Fam Med 2012;33:152–6
   PubMedGoogle Scholar
• Hong D, Kim Y, Son E, et al. Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men. Maturitas 2013;74:148–53
   PubMed Web of Science ®Google Scholar
• Liu, R, Chung M, Wang P, et al. The prevalence and predictors of androgen deficiency in Taiwanese men with type 2 diabetes. Urology 2013;82:124–9
   PubMedGoogle Scholar
• Chin K, Ima-Nirwana S, Mohaned I, et al. Total testosterone and sex hormone-binding globulin are significantly associated with metabolic syndrome in middle-aged and elderly men. Exp Clin Endocrinol Diabetes 2013;121:407–12
   PubMedGoogle Scholar
• Vermeulen A, Goemaere S, Kaufman J. Testosterone, body composition and aging. J Endocrinol Invest 1999;22:110–16
   PubMedGoogle Scholar
• Harman S, Miller E, Tobin J, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724–31
   PubMed Web of Science ®Google Scholar
• Ponholzer A, Plas E, Schatzl G, et al. Relationship between testosterone serum levels and lifestyle in aging men. Aging Male 2005;8:190–3
   PubMedGoogle Scholar
• Travison T, Araujo A, Kupelian V, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clinical Endocrin Metab 2007;92:549–55
   PubMed Web of Science ®Google Scholar
• Saad, F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity 2013;21:1975–81
   PubMed Web of Science ®Google Scholar
• Botella-Carretero J, Balsa J, Gomez-Martin J, et al. Circulating free testosterone in obese men after biariatric surgery increases in parallel with insulin sensitivity. J Endocrinol Invest 2013;36:227–32
   PubMed Web of Science ®Google Scholar
• Saylor P, Smith M. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urology 2009;181:1998–2006
   PubMed Web of Science ®Google Scholar
• Rubinow K, Snyder C, Amory J, et al. Acute testosterone deprivation reduces insulin sensitivity in men. Clin Endocrinol 2012;76:281–8
   PubMed Web of Science ®Google Scholar
• Corona G, Monami M, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 2010;34:528–40
   PubMedGoogle Scholar
• Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011;165:687–701
   PubMed Web of Science ®Google Scholar
• Muraleedharan V, Marsh H, Kapoor D, et al. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 2013;169:725–33
   PubMed Web of Science ®Google Scholar
• Buffler P, Ginevan M, Mandel J, Watkins D. The Air Force Health Study: an epidemiologic retrospective. Ann Epidemiol 2011;21:673–87
   PubMedGoogle Scholar
• Michalek J, Pavuk M. Diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spend in Southeast Asia. JOEM 2008;50:330–40
   Google Scholar
• Mazur A, Michalek J. Marriage, divorce and male testosterone. Social Forces 1998;77:315–30
   Web of Science ®Google Scholar
• CDC. 2010. Healthy People 2010 Final Review. Atlanta, GA
   Google Scholar
• Jones T, Arver S, Behre H, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome. Diabetes Care 2011;34:828–37
   PubMed Web of Science ®Google Scholar
• Hackett G. Testosterone and the heart. Int J Clin Pract 2012;66:648–55
   PubMedGoogle Scholar